bit.bio raises $25M Series D as demand for its human cell models grows

Cambridge-based biotech company bit.bio has raised $25M in a Series D round, ten months after securing its previous investment. The company announced the new funding on Wednesday, with backing from existing investor M&G Investments and Dr Jonathan Milner, founder and former chief executive of research tools company Abcam. bit.bio did not disclose a lead investor […] This story continues at The Next Web